A phase I/II trial of trastuzumab and gefitinib in patients with metastatic breast cancer that overexpresses HER2/neu (ErbB-2)

Stacy L. Moulder, Carlos L. Arteaga

Research output: Contribution to journalArticle

33 Scopus citations
Original languageEnglish (US)
Pages (from-to)142-145
Number of pages4
JournalClinical breast cancer
Volume4
Issue number2
DOIs
StatePublished - Jun 2003

Keywords

  • Combined therapy
  • EGFR
  • Small-molecule inhibitors
  • ZD1839

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this